Cited by 26Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

Hepatic Oxi-Inflammation and Neophobia as Potential Liver–Brain Axis Targets for Alzheimer’s Disease and Aging, with Strong Sensitivity to Sex, Isolation, and Obesity

Open access
Fraile-Ramos, Juan, Garrit, Anna, Reig-Vilallonga, Josep, Giménez-Llort, Lydia·2023·Cells

Abstract

Research on Alzheimer’s disease (AD) has classically focused on alterations that occur in the brain and their intra- and extracellular neuropathological hallmarks. However, the oxi-inflammation hypothesis of aging may also play a role in neuroimmunoendocrine dysregulation and the disease’s pathophysiology, where the liver emerges as a target organ due to its implication in regulating metabolism and supporting the immune system. In the present work, we demonstrate organ (hepatomegaly), tissue (histopathological amyloidosis), and cellular oxidative stress (decreased glutathione peroxidase and increased glutathione reductase enzymatic activities) and inflammation (increased IL-6 and TNF𝛼) as hallmarks of hepatic dysfunction in 16-month-old male and female 3xTg-AD mice at advanced stages of the disease, and as compared to age- and sex-matched non-transgenic (NTg) counterparts. Moreover, liver–brain axis alterations were found through behavioral (increased neophobia) and HPA axis correlations that were enhanced under forced isolation. In all cases, sex (male) and isolation (naturalistic and forced) were determinants of worse hepatomegaly, oxidative stress, and inflammation progression. In addition, obesity in old male NTg mice was translated into a worse steatosis grade. Further research is underway determine whether these alterations could correlate with a worse disease prognosis and to establish potential integrative system targets for AD research.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells12111517

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 82

  1. [1]García-Mesa Y. Colie S. Corpas R. Cristòfol R. Comellas F. Nebreda A.R. Giménez-Llort L. Sanfeliu C. Oxidative Stress Is a Central Target for Physical Exercise Neuroprotection Against Pathological Brain Aging J. Gerontol. A Biol. Sci. Med. Sci. 2016 71 40 49 10.1093/gerona/glv005 25720862 · DOI
  2. [2]Tiwari S. Atluri V. Kaushik A. Yndart A. Nair M. Alzheimer’s Disease: Pathogenesis, Diagnostics, and Therapeutics Int. J. Nanomed. 2019 14 5541 5554 10.2147/IJN.S200490 31410002 PMC6650620 · DOI · Paper page
  3. [3]Scheltens P. De Strooper B. Kivipelto M. Holstege H. Chételat G. Teunissen C.E. Cummings J. van der Flier W.M. Alzheimer’s Disease Lancet 2021 397 1577 1590 10.1016/S0140-6736(20)32205-4 33667416 PMC8354300 · DOI · Paper page
  4. [4]Alzheimer’s Association 2021 Alzheimer’s Disease Facts and Figures Alzheimer’s Dement. 2021 17 327 406 10.1002/alz.12328 33756057 · DOI
  5. [5]Hasegawa M. Molecular Mechanisms in the Pathogenesis of Alzheimer’s Disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation Biomolecules 2016 6 24 10.3390/biom6020024 27136595 PMC4919919 · DOI
  6. [6]Vida C. Martinez de Toda I. Garrido A. Carro E. Molina J.A. De la Fuente M. Impairment of Several Immune Functions and Redox State in Blood Cells of Alzheimer’s Disease Patients. Relevant Role of Neutrophils in Oxidative Stress Front. Immunol. 2018 8 1974 10.3389/fimmu.2017.01974 29375582 PMC5768621 · DOI
  7. [7]Morris G. Berk M. Maes M. Puri B.K. Could Alzheimer’s Disease Originate in the Periphery and If So How So? Mol. Neurobiol. 2019 56 406 434 10.1007/s12035-018-1092-y 29705945 PMC6372984 · DOI
  8. [8]Gibson G.E. Huang H.-M. Oxidative Stress in Alzheimer’s Disease Neurobiol. Aging 2005 26 575 578 10.1016/j.neurobiolaging.2004.07.017 15708429 · DOI
  9. [9]Pugazhenthi S. Qin L. Reddy P.H. Common Neurodegenerative Pathways in Obesity, Diabetes, and Alzheimer’s Disease Biochim. Biophys. Acta (BBA)—Mol. Basis Dis. 2017 1863 1037 1045 10.1016/j.bbadis.2016.04.017 PMC5344771 27156888 · DOI · Paper page
  10. [10]Muntsant A. Giménez-Llort L. Crosstalk of Alzheimer’s Disease-Phenotype, HPA Axis, Splenic Oxidative Stress and Frailty in Late-Stages of Dementia, with Special Concerns on the Effects of Social Isolation: A Translational Neuroscience Approach Front. Aging Neurosci. 2022 14 969381 10.3389/fnagi.2022.969381 36185472 PMC9520301 · DOI
  11. [11]Baeta-Corral R. De la Fuente M. Giménez-Llort L. Sex-Dependent Worsening of NMDA-Induced Responses, Anxiety, Hypercortisolemia, and Organometry of Early Peripheral Immunoendocrine Impairment in Adult 3xTg-AD Mice and Their Long-Lasting Ontogenic Modulation by Neonatal Handling Behav. Brain Res. 2023 438 114189 10.1016/j.bbr.2022.114189 36343697 · DOI
  12. [12]Angiulli F. Conti E. Zoia C.P. Da Re F. Appollonio I. Ferrarese C. Tremolizzo L. Blood-Based Biomarkers of Neuroinflammation in Alzheimer’s Disease: A Central Role for Periphery? Diagnostics 2021 11 1525 10.3390/diagnostics11091525 34573867 PMC8464786 · DOI
  13. [13]Racanelli V. Rehermann B. The Liver as an Immunological Organ Hepatology 2006 43 S54 S62 10.1002/hep.21060 16447271 · DOI · Paper page
  14. [14]Sarkar S.R. Dutta R. Role of Liver in Alzheimer’s Disease ARC J. Neurosci. 2020 4 20 25 10.20431/2456-057x.0403003 · DOI
  15. [15]Li S. Hong M. Tan H.-Y. Wang N. Feng Y. Insights into the Role and Interdependence of Oxidative Stress and Inflammation in Liver Diseases Oxidative Med. Cell. Longev. 2016 2016 4234061 10.1155/2016/4234061 PMC5192343 28070230 · DOI
  16. [16]Nho K. Kueider-Paisley A. Ahmad S. MahmoudianDehkordi S. Arnold M. Risacher S.L. Louie G. Blach C. Baillie R. Han X. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers JAMA Netw. Open 2019 2 e197978 10.1001/jamanetworkopen.2019.7978 31365104 PMC6669786 · DOI · Paper page
  17. [17]Huang Z. Lin H.W. Zhang Q. Zong X. Targeting Alzheimer’s Disease: The Critical Crosstalk between the Liver and Brain Nutrients 2022 14 4298 10.3390/nu14204298 36296980 PMC9609624 · DOI · Paper page
  18. [18]Estrada L.D. Ahumada P. Cabrera D. Arab J.P. Liver Dysfunction as a Novel Player in Alzheimer’s Progression: Looking Outside the Brain Front. Aging Neurosci. 2019 11 174 10.3389/fnagi.2019.00174 31379558 PMC6650779 · DOI · Paper page
  19. [19]Gimenez-Llort L. De Las Casas-Engel M. Laferla F.M. De La Fuente M. P4-245: Decrease of the Antioxidant Defenses in 3xTg-AD Triple-transgenic Adult Mice for Alzheimer’s Disease Alzheimer’s Dement. 2009 5 P502 10.1016/j.jalz.2009.04.711 · DOI
  20. [20]Hernanz A. Vida C. Manassra R. Gimenez-Llort L. De la Fuente M. P2-063: Early Peripheral Oxidative Stress Status In Male And Female Triple-Transgenic Mice For Alzheimer’s Disease Alzheimer’s Dement. 2014 10 P492 P493 10.1016/j.jalz.2014.05.737 · DOI
  21. [21]Cummings J.L. The Neuropsychiatric Inventory: Assessing Psychopathology in Dementia Patients Neurology 1997 48 10S 16S 10.1212/WNL.48.5_Suppl_6.10S 9153155 · DOI
  22. [22]Oddo S. Caccamo A. Shepherd J.D. Murphy M.P. Golde T.E. Kayed R. Metherate R. Mattson M.P. Akbari Y. LaFerla F.M. Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles Neuron 2003 39 409 421 10.1016/S0896-6273(03)00434-3 12895417 · DOI · Paper page
  23. [23]Giménez-Llort L. Arranz L. Maté I. De la Fuente M. Gender-Specific Neuroimmunoendocrine Aging in a Triple-Transgenic 3×Tg-AD Mouse Model for Alzheimer’s Disease and Its Relation with Longevity Neuroimmunomodulation 2008 15 331 343 10.1159/000156475 19047809 · DOI · Paper page
  24. [24]Giménez-Llort L. Blázquez G. Cañete T. Johansson B. Oddo S. Tobeña A. LaFerla F.M. Fernández-Teruel A. Modeling Behavioral and Neuronal Symptoms of Alzheimer’s Disease in Mice: A Role for Intraneuronal Amyloid Neurosci. Biobehav. Rev. 2007 31 125 147 10.1016/j.neubiorev.2006.07.007 17055579 · DOI
  25. [25]Ahmad M.H. Fatima M. Mondal A.C. Role of Hypothalamic-Pituitary-Adrenal Axis, Hypothalamic-Pituitary-Gonadal Axis and Insulin Signaling in the Pathophysiology of Alzheimer’s Disease Neuropsychobiology 2019 77 197 205 10.1159/000495521 30605907 · DOI
  26. [26]Giménez-Llort L. Maté I. Manassra R. Vida C. De la Fuente M. Peripheral Immune System and Neuroimmune Communication Impairment in a Mouse Model of Alzheimer’s Disease Ann. N. Y. Acad. Sci. 2012 1262 74 84 10.1111/j.1749-6632.2012.06639.x 22823438 · DOI
  27. [27]De la Fuente M. Manassra R. Mate I. Vida C. Hernanz A. Gimenez-Llort L. Early Oxidation and Inflammation State of the Immune System in Male and Female Triple Transgenic Mice for Alzheimer’s Disease (3xTgAD) Free Radic. Biol. Med. 2012 53 S165 10.1016/j.freeradbiomed.2012.08.346 · DOI
  28. [28]Maté I. Cruces J. Giménez-Llort L. De la Fuente M. Function and Redox State of Peritoneal Leukocytes as Preclinical and Prodromic Markers in a Longitudinal Study of Triple-Transgenic Mice for Alzheimer’s Disease J. Alzheimer’s Dis. 2014 43 213 226 10.3233/JAD-140861 25079793 · DOI
  29. [29]Blázquez G. Cañete T. Tobeña A. Giménez-Llort L. Fernández-Teruel A. Cognitive and Emotional Profiles of Aged Alzheimer’s Disease (3×TgAD) Mice: Effects of Environmental Enrichment and Sexual Dimorphism Behav. Brain Res. 2014 268 185 201 10.1016/j.bbr.2014.04.008 24746486 · DOI
  30. [30]Esmaeili M.H. Bahari B. Salari A.-A. ATP-Sensitive Potassium-Channel Inhibitor Glibenclamide Attenuates HPA Axis Hyperactivity, Depression- and Anxiety-Related Symptoms in a Rat Model of Alzheimer’s Disease Brain Res. Bull. 2018 137 265 276 10.1016/j.brainresbull.2018.01.001 29307659 · DOI
  31. [31]Feng Y. Hu Y. Hou Z. Sun Q. Jia Y. Zhao R. Chronic Corticosterone Exposure Induces Liver Inflammation and Fibrosis in Association with M6A-Linked Post-Transcriptional Suppression of Heat Shock Proteins in Chicken Cell Stress Chaperones 2020 25 47 56 10.1007/s12192-019-01034-7 31745845 PMC6985306 · DOI
  32. [32]Berkman L.F. Glass T. Brissette I. Seeman T.E. From Social Integration to Health: Durkheim in the New Millennium Soc. Sci. Med. 2000 51 843 857 10.1016/S0277-9536(00)00065-4 10972429 · DOI · Paper page
  33. [33]Muntsant A. Giménez-Llort L. Impact of Social Isolation on the Behavioral, Functional Profiles, and Hippocampal Atrophy Asymmetry in Dementia in Times of Coronavirus Pandemic (COVID-19): A Translational Neuroscience Approach Front. Psychiatry 2020 11 572583 10.3389/fpsyt.2020.572583 33329110 PMC7732415 · DOI
  34. [34]Gimenez-Llort L. Alveal-Mellado D. Digging Signatures in 13-Month-Old 3xTg-AD Mice for Alzheimer’s Disease and Its Disruption by Isolation Despite Social Life Since They Were Born Front. Behav. Neurosci. 2021 14 611384 10.3389/fnbeh.2020.611384 33536883 PMC7847935 · DOI
  35. [35]Baeza I. De Castro N.M. Giménez-Llort L. De la Fuente M. Ovariectomy, a Model of Menopause in Rodents, Causes a Premature Aging of the Nervous and Immune Systems J. Neuroimmunol. 2010 219 90 99 10.1016/j.jneuroim.2009.12.008 20096467 · DOI
  36. [36]Torres-Lista V. De la Fuente M. Giménez-Llort L. Survival Curves and Behavioral Profiles of Female 3xTg-AD Mice Surviving to 18-Months of Age as Compared to Mice with Normal Aging J. Alzheimers Dis. Rep. 2017 1 47 57 10.3233/ADR-170011 30480229 PMC6159713 · DOI
  37. [37]Jack C.R. Lowe V.J. Weigand S.D. Wiste H.J. Senjem M.L. Knopman D.S. Shiung M.M. Gunter J.L. Boeve B.F. Kemp B.J. Serial PIB and MRI in Normal, Mild Cognitive Impairment and Alzheimer’s Disease: Implications for Sequence of Pathological Events in Alzheimer’s Disease Brain 2009 132 1355 1365 10.1093/brain/awp062 19339253 PMC2677798 · DOI · Paper page
  38. [38]Baeta-Corral R. Giménez-Llort L. Persistent Hyperactivity and Distinctive Strategy Features in the Morris Water Maze in 3xTg-AD Mice at Advanced Stages of Disease Behav. Neurosci. 2015 129 129 137 10.1037/bne0000027 25730122 · DOI
  39. [39]Kilkenny C. Browne W.J. Cuthill I.C. Emerson M. Altman D.G. Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research PLoS Biol. 2010 8 e1000412 10.1371/journal.pbio.1000412 20613859 PMC2893951 · DOI · Paper page
  40. [40]Tietze F. Enzymic Method for Quantitative Determination of Nanogram Amounts of Total and Oxidized Glutathione: Applications to Mammalian Blood and Other Tissues Anal. Biochem. 1969 27 502 522 10.1016/0003-2697(69)90064-5 4388022 · DOI
  41. [41]Rahman I. Kode A. Biswas S.K. Assay for Quantitative Determination of Glutathione and Glutathione Disulfide Levels Using Enzymatic Recycling Method Nat. Protoc. 2006 1 3159 3165 10.1038/nprot.2006.378 17406579 · DOI
  42. [42]Massey V. Williams C.H. On the Reaction Mechanism of Yeast Glutathione Reductase J. Biol. Chem. 1965 240 4470 4480 10.1016/S0021-9258(18)97085-7 4378936 · DOI
  43. [43]Lawrence R.A. Burk R.F. Glutathione Peroxidase Activity in Selenium-Deficient Rat Liver Biochem. Biophys. Res. Commun. 1976 71 952 958 10.1016/0006-291X(76)90747-6 971321 · DOI
  44. [44]Alvarado C. Álvarez P. Jiménez L. De la Fuente M. Oxidative Stress in Leukocytes from Young Prematurely Aging Mice Is Reversed by Supplementation with Biscuits Rich in Antioxidants Dev. Comp. Immunol. 2006 30 1168 1180 10.1016/j.dci.2006.03.004 16690124 · DOI
  45. [45]Trefts E. Gannon M. Wasserman D.H. The Liver Curr. Biol. 2017 27 R1147 R1151 10.1016/j.cub.2017.09.019 29112863 PMC5897118 · DOI · Paper page
  46. [46]Muntsant A. Giménez-Llort L. Genotype Load Modulates Amyloid Burden and Anxiety-Like Patterns in Male 3xTg-AD Survivors despite Similar Neuro-Immunoendocrine, Synaptic and Cognitive Impairments Biomedicines 2021 9 715 10.3390/biomedicines9070715 34201608 PMC8301351 · DOI
  47. [47]De la Fuente M. Gimenez-Llort L. Models of Aging of Neuroimmunomodulation: Strategies for Its Improvement Neuroimmunomodulation 2010 17 213 216 10.1159/000258727 20134206 · DOI
  48. [48]Siersbæk M.S. Ditzel N. Hejbøl E.K. Præstholm S.M. Markussen L.K. Avolio F. Li L. Lehtonen L. Hansen A.K. Schrøder H.D. C57BL/6J Substrain Differences in Response to High-Fat Diet Intervention Sci. Rep. 2020 10 14052 10.1038/s41598-020-70765-w 32820201 PMC7441320 · DOI
  49. [49]Li J. Wu H. Liu Y. Yang L. High Fat Diet Induced Obesity Model Using Four Strains of Mice: Kunming, C57BL/6, BALB/c and ICR Exp. Anim. 2020 69 326 335 10.1538/expanim.19-0148 32188837 PMC7445062 · DOI
  50. [50]Friedman S.L. Neuschwander-Tetri B.A. Rinella M. Sanyal A.J. Mechanisms of NAFLD Development and Therapeutic Strategies Nat. Med. 2018 24 908 922 10.1038/s41591-018-0104-9 29967350 PMC6553468 · DOI · Paper page
  51. [51]Ipsen D.H. Lykkesfeldt J. Tveden-Nyborg P. Molecular Mechanisms of Hepatic Lipid Accumulation in Non-Alcoholic Fatty Liver Disease Cell. Mol. Life Sci. 2018 75 3313 3327 10.1007/s00018-018-2860-6 29936596 PMC6105174 · DOI · Paper page
  52. [52]Simon G. Heckmann V. Tóth D. Pauka D. Petrus K. Molnár T.F. The Effect of Hepatic Steatosis and Fibrosis on Liver Weight and Dimensions Leg. Med. 2020 47 101781 10.1016/j.legalmed.2020.101781 32889367 · DOI
  53. [53]Sarkar S. Raymick J. Cuevas E. Rosas-Hernandez H. Hanig J. Modification of Methods to Use Congo-Red Stain to Simultaneously Visualize Amyloid Plaques and Tangles in Human and Rodent Brain Tissue Sections Metab. Brain Dis. 2020 35 1371 1383 10.1007/s11011-020-00608-0 32852699 · DOI
  54. [54]Clement C.G. Truong L.D. An Evaluation of Congo Red Fluorescence for the Diagnosis of Amyloidosis Hum. Pathol. 2014 45 1766 1772 10.1016/j.humpath.2014.04.016 24935061 · DOI
  55. [55]Gioeva Z. Kieninger B. Röcken C. Amyloidose in Leberbiopsien Pathologe 2009 30 240 245 10.1007/s00292-009-1133-4 19415368 · DOI
  56. [56]Muchtar E. Dispenzieri A. Magen H. Grogan M. Mauermann M. McPhail E.D. Kurtin P.J. Leung N. Buadi F.K. Dingli D. Systemic Amyloidosis from A (AA) to T (ATTR): A Review J. Intern. Med. 2021 289 268 292 10.1111/joim.13169 32929754 · DOI
  57. [57]Wiȩckowska-Gacek A. Mietelska-Porowska A. Chutorański D. Wydrych M. Długosz J. Wojda U. Western Diet Induces Impairment of Liver-Brain Axis Accelerating Neuroinflammation and Amyloid Pathology in Alzheimer’s Disease Front. Aging Neurosci. 2021 13 654509 10.3389/fnagi.2021.654509 33867971 PMC8046915 · DOI
  58. [58]Cheng Y. Tian D.-Y. Wang Y.-J. Peripheral Clearance of Brain-Derived Aβ in Alzheimer’s Disease: Pathophysiology and Therapeutic Perspectives Transl. Neurodegener. 2020 9 16 10.1186/s40035-020-00195-1 32381118 PMC7204069 · DOI
  59. [59]González-Marrero I. Giménez-Llort L. Johanson C.E. Carmona-Calero E.M. Castañeyra-Ruiz L. Brito-Armas J.M. Castañeyra-Perdomo A. Castro-Fuentes R. Choroid Plexus Dysfunction Impairs Beta-Amyloid Clearance in a Triple Transgenic Mouse Model of Alzheimer’s Disease Front. Cell. Neurosci. 2015 9 17 10.3389/fncel.2015.00017 25705176 PMC4319477 · DOI
  60. [60]Marchese M. Cowan D. Head E. Ma D. Karimi K. Ashthorpe V. Kapadia M. Zhao H. Davis P. Sakic B. Autoimmune Manifestations in the 3xTg-AD Model of Alzheimer’s Disease J. Alzheimer’s Dis. 2014 39 191 210 10.3233/JAD-131490 24150111 PMC4376359 · DOI · Paper page
  61. [61]Machado M.V. Cortez-Pinto H. Cell Death and Nonalcoholic Steatohepatitis: Where Is Ballooning Relevant? Expert Rev. Gastroenterol. Hepatol. 2011 5 213 222 10.1586/egh.11.16 21476916 · DOI
  62. [62]Lackner C. Hepatocellular Ballooning in Nonalcoholic Steatohepatitis: The Pathologist’s Perspective Expert Rev. Gastroenterol. Hepatol. 2011 5 223 231 10.1586/egh.11.8 21476917 · DOI
  63. [63]Presnell E.C. Bhatti G. Numan L.S. Lerche M. Alkhateeb S.K. Ghalib M. Shammaa M. Kavdia M. Computational Insights into the Role of Glutathione in Oxidative Stress Curr. Neurovascular Res. 2013 10 185 194 10.2174/1567202611310020011 23469953 · DOI
  64. [64]Wu G. Lupton J.R. Turner N.D. Fang Y.-Z. Yang S. Glutathione Metabolism and Its Implications for Health J. Nutr. 2004 134 489 492 10.1093/jn/134.3.489 14988435 · DOI · Paper page
  65. [65]Sentellas S. Morales-Ibanez O. Zanuy M. Albertí J.J. GSSG/GSH Ratios in Cryopreserved Rat and Human Hepatocytes as a Biomarker for Drug Induced Oxidative Stress Toxicol. Vitr. 2014 28 1006 1015 10.1016/j.tiv.2014.04.017 24809893 · DOI
  66. [66]Zitka O. Skalickova S. Gumulec J. Masarik M. Adam V. Hubalek J. Trnkova L. Kruseova J. Eckschlager T. Kizek R. Redox Status Expressed as GSH:GSSG Ratio as a Marker for Oxidative Stress in Paediatric Tumour Patients Oncol. Lett. 2012 4 1247 1253 10.3892/ol.2012.931 23205122 PMC3506742 · DOI · Paper page
  67. [67]Han D. Hanawa N. Saberi B. Kaplowitz N. Mechanisms of Liver Injury. III. Role of Glutathione Redox Status in Liver Injury Am. J. Physiol.-Gastrointest. Liver Physiol. 2006 291 G1 G7 10.1152/ajpgi.00001.2006 16500922 · DOI
  68. [68]Chen J. Bhandar B. Kavdia M. Interaction of ROS and RNS with GSH and GSH/GPX Systems FASEB J. 2015 29 636.7 10.1096/fasebj.29.1_supplement.636.7 · DOI
  69. [69]Ferre N. Claria J. New Insights into the Regulation of Liver Inflammation and Oxidative Stress Mini-Rev. Med. Chem. 2006 6 1321 1330 10.2174/138955706778993049 17168808 · DOI
  70. [70]Lyketsos C.G. Carrillo M.C. Ryan J.M. Khachaturian A.S. Trzepacz P. Amatniek J. Cedarbaum J. Brashear R. Miller D.S. Neuropsychiatric Symptoms in Alzheimer’s Disease Alzheimer’s Dement. 2011 7 532 539 10.1016/j.jalz.2011.05.2410 21889116 PMC3299979 · DOI · Paper page
  71. [71]Canet G. Hernandez C. Zussy C. Chevallier N. Desrumaux C. Givalois L. Is AD a Stress-Related Disorder? Focus on the HPA Axis and Its Promising Therapeutic Targets Front. Aging Neurosci. 2019 11 269 10.3389/fnagi.2019.00269 31611783 PMC6776918 · DOI
  72. [72]Kosel F. Pelley J.M.S. Franklin T.B. Behavioural and Psychological Symptoms of Dementia in Mouse Models of Alzheimer’s Disease-Related Pathology Neurosci. Biobehav. Rev. 2020 112 634 647 10.1016/j.neubiorev.2020.02.012 32070692 · DOI
  73. [73]Nguyen E.T. Selmanovic D. Maltry M. Morano R. Franco-Villanueva A. Estrada C.M. Solomon M.B. Endocrine Stress Responsivity and Social Memory in 3xTg-AD Female and Male Mice: A Tale of Two Experiments Horm. Behav. 2020 126 104852 10.1016/j.yhbeh.2020.104852 32949555 · DOI
  74. [74]Xie X. Shen Q. Yu C. Xiao Q. Zhou J. Xiong Z. Li Z. Fu Z. Depression-like Behaviors Are Accompanied by Disrupted Mitochondrial Energy Metabolism in Chronic Corticosterone-Induced Mice J. Steroid Biochem. Mol. Biol. 2020 200 105607 10.1016/j.jsbmb.2020.105607 32045672 · DOI
  75. [75]Liao J. Keiser J.A. Scales W.E. Kunkel S.L. Kluger M.J. Role of Corticosterone in TNF and IL-6 Production in Isolated Perfused Rat Liver Am. J. Physiol.-Regul. Integr. Comp. Physiol. 1995 268 R699 R706 10.1152/ajpregu.1995.268.3.R699 7900913 · DOI
  76. [76]Battaglia S. Thayer J.F. Functional Interplay between Central and Autonomic Nervous Systems in Human Fear Conditioning Trends Neurosci. 2022 45 504 506 10.1016/j.tins.2022.04.003 35577621 · DOI
  77. [77]Battaglia S. Orsolini S. Borgomaneri S. Barbieri R. Diciotti S. di Pellegrino G. Characterizing Cardiac Autonomic Dynamics of Fear Learning in Humans Psychophysiology 2022 59 e14122 10.1111/psyp.14122 35671393 PMC9787647 · DOI
  78. [78]Villagarcía H.G. Sabugo V. Castro M.C. Schinella G. Castrogiovanni D. Spinedi E. Massa M.L. Francini F. Chronic Glucocorticoid-Rich Milieu and Liver Dysfunction Int. J. Endocrinol. 2016 2016 7838290 10.1155/2016/7838290 27597864 PMC4997070 · DOI
  79. [79]Baliño P. Romero-Cano R. Sánchez-Andrés J.V. Valls V. Aragón C.G. Muriach M. Effects of Acute Ethanol Administration on Brain Oxidative Status: The Role of Acetaldehyde Alcohol. Clin. Exp. Res. 2019 43 1672 1681 10.1111/acer.14133 31211868 · DOI
  80. [80]Tao W. Sun W. Liu L. Wang G. Xiao Z. Pei X. Wang M. Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice Mar. Drugs 2019 17 645 10.3390/md17110645 31744059 PMC6891487 · DOI
  81. [81]Ke Z. Zhao Y. Tan S. Chen H. Li Y. Zhou Z. Huang C. Citrus Reticulata Blanco Peel Extract Ameliorates Hepatic Steatosis, Oxidative Stress and Inflammation in HF and MCD Diet-Induced NASH C57BL/6 J Mice J. Nutr. Biochem. 2020 83 108426 10.1016/j.jnutbio.2020.108426 32559586 · DOI
  82. [82]Shen L.-X. Yang Y.-X. Kuo K. Li H.-Q. Chen S.-D. Chen K.-L. Dong Q. Tan L. Yu J.-T. Social Isolation, Social Interaction, and Alzheimer’s Disease: A Mendelian Randomization Study J. Alzheimer’s Dis. 2021 80 665 672 10.3233/JAD-201442 33579855 · DOI

Cited by

Sorted by citations

Authors
Fraile-Ramos, J., Garrit, A., Reig-Vilallonga, J., & Giménez-Llort, L.
Affiliations
  • Universitat Autònoma de Barcelona (ES)
  • Department of Anatomy, School of Medicine, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain
  • Institut de Neurociències, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain
Venue
Cells
Publisher
MDPI AG
Published
2023-05-30
Volume
12
Issue
11
Pages
1517
ISSN
2073-4409 (ISSN-L)
OpenAlex
W4378904537
Cited by
26
References
0
Citations by year
2026: 3 · 2025: 9 · 2024: 11 · 2023: 3
FWCI
6.18
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • AGAUR, Generalitat de Catalunya (2017-SGR-1468, UAB-GE-260408, Fet-OPEN-1-2016-2017-737390, 737390, 2021/80/09241941.8)
  • Universitat Autònoma de Barcelona (2017-SGR-1468, UAB-GE-260408, Fet-OPEN-1-2016-2017-737390, 737390, 2021/80/09241941.8)
  • ArrestAD H2020 (2017-SGR-1468, UAB-GE-260408, Fet-OPEN-1-2016-2017-737390, 737390, 2021/80/09241941.8)
  • European Union’s Horizon 2020 research and innovation program (2017-SGR-1468, UAB-GE-260408, Fet-OPEN-1-2016-2017-737390, 737390, 2021/80/09241941.8)
  • Memorial Mercedes Llort Sender (2017-SGR-1468, UAB-GE-260408, Fet-OPEN-1-2016-2017-737390, 737390, 2021/80/09241941.8)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, liver-brain axis, hepatic oxidative stress, liver inflammation, hepatomegaly, amyloidosis, glutathione peroxidase, glutathione reductase, interleukin-6, TNF-α, 3xTg-AD mice, aging, sex differences, social isolation, hypothalamic-pituitary-adrenal axis, neophobia, obesity, hepatic steatosis
MeSH terms
Aging, Alzheimer Disease, Animals, Brain, Female, Hepatomegaly, Hypothalamo-Hypophyseal System, Inflammation, Male, Mice, Transgenic, Obesity, Pituitary-Adrenal System, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review